eli lilly cash pay tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Eli Lilly Adds Highest Doses

Targeting the right genetic pathways may help alleviate reactions

Heilmann RM, Suchodolski JS

A study published this month in The Lancet involving about 95,000 people found that among those with diabetes or obesity who also have depression or anxiety, semaglutide (the active ingredient in Novo Nordisks Ozempic and Wegovy) was linked to a lower risk of worsening depression, anxiety, substance use disorder and self-harm - though the results show correlation, not causation

Gastrointestinal symptoms are the most frequently reported issues, with nausea being the most common

406 Wei et al

Always follow the instructions on the bottle or your doctors advice